Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal
Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer
Tyrosine Kinase Inhibitor Encoraging For NSCLC
Novel Agents Promise Relief From Hematologic Side Effects
Interferon Alpha-2B Effective For Malignant Melanoma
International Group Plans Survey On Thrombosis Risk
NCI-Approved Clinical Trials Listed For June 2001
Trending Stories
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation - A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Group chairs propose funding strategy to jump-start correlative studies
- Karen Knudsen to leave ACS
- 2024 Lasker Awards honor discoveries in antitumor immunity, GLP-1-based drugs, and research, advocacy in HIV/AIDS